Australia markets closed

Conduit Pharmaceuticals Inc. (CDT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.9700+0.0300 (+1.02%)
At close: 04:00PM EDT
2.9700 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 217.06M
Enterprise value 216.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.50
52-week change 3-72.16%
S&P500 52-week change 326.36%
52-week high 325.0000
52-week low 30.9500
50-day moving average 33.1781
200-day moving average 34.7298

Share statistics

Avg vol (3-month) 329.22k
Avg vol (10-day) 323.92k
Shares outstanding 573.83M
Implied shares outstanding 673.83M
Float 818.9M
% held by insiders 186.65%
% held by institutions 12.01%
Shares short (30 Apr 2024) 442.49k
Short ratio (30 Apr 2024) 41.4
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.06%
Shares short (prior month 28 Mar 2024) 455.11k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-90.99%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-535k
Diluted EPS (ttm)-0.0900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.23M
Total cash per share (mrq)0.06
Total debt (mrq)985k
Total debt/equity (mrq)N/A
Current ratio (mrq)3.18
Book value per share (mrq)-0.01

Cash flow statement

Operating cash flow (ttm)-7.72M
Levered free cash flow (ttm)N/A